These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 8098733)
1. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. Sypek JP; Chung CL; Mayor SE; Subramanyam JM; Goldman SJ; Sieburth DS; Wolf SF; Schaub RG J Exp Med; 1993 Jun; 177(6):1797-802. PubMed ID: 8098733 [TBL] [Abstract][Full Text] [Related]
2. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Scott P J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466 [TBL] [Abstract][Full Text] [Related]
4. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection. Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076 [TBL] [Abstract][Full Text] [Related]
5. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Heinzel FP; Sadick MD; Holaday BJ; Coffman RL; Locksley RM J Exp Med; 1989 Jan; 169(1):59-72. PubMed ID: 2521244 [TBL] [Abstract][Full Text] [Related]
6. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Varkila K; Chatelain R; Leal LM; Coffman RL Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179 [TBL] [Abstract][Full Text] [Related]
7. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. Scharton TM; Scott P J Exp Med; 1993 Aug; 178(2):567-77. PubMed ID: 8101861 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma inhibits the efficacy of interleukin 1 to generate a Th2-cell biased immune response induced by Leishmania major. Wagner HM; Beuscher HU; Röllinghoff M; Solbach W Immunobiology; 1991 Jun; 182(3-4):292-306. PubMed ID: 1680802 [TBL] [Abstract][Full Text] [Related]
9. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. Sadick MD; Locksley RM; Tubbs C; Raff HV J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789 [TBL] [Abstract][Full Text] [Related]
10. Analysis of cytokine patterns produced by individual CD4+ lymph node cells during experimental murine leishmaniasis in resistant and susceptible mice. Sommer F; Meixner M; Mannherz M; Ogilvie AL; Röllinghoff M; Lohoff M Int Immunol; 1998 Dec; 10(12):1853-61. PubMed ID: 9885906 [TBL] [Abstract][Full Text] [Related]
11. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection. Yamakami K; Akao S; Sato M; Nitta Y; Miyazaki J; Tadakuma T Parasitol Int; 2001 Jul; 50(2):81-91. PubMed ID: 11438430 [TBL] [Abstract][Full Text] [Related]
12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560 [TBL] [Abstract][Full Text] [Related]
13. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. Heinzel FP; Rerko RM; Ahmed F; Pearlman E J Immunol; 1995 Jul; 155(2):730-9. PubMed ID: 7608551 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Germann T; Gately MK; Schoenhaut DS; Lohoff M; Mattner F; Fischer S; Jin SC; Schmitt E; Rüde E Eur J Immunol; 1993 Aug; 23(8):1762-70. PubMed ID: 8102100 [TBL] [Abstract][Full Text] [Related]
16. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states. Bretscher PA; Ogunremi O; Menon JN Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736 [TBL] [Abstract][Full Text] [Related]
17. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. Heinzel FP; Rerko RM; Hatam F; Locksley RM J Immunol; 1993 May; 150(9):3924-31. PubMed ID: 8473741 [TBL] [Abstract][Full Text] [Related]
18. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. Swihart K; Fruth U; Messmer N; Hug K; Behin R; Huang S; Del Giudice G; Aguet M; Louis JA J Exp Med; 1995 Mar; 181(3):961-71. PubMed ID: 7869054 [TBL] [Abstract][Full Text] [Related]
19. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. Morris L; Troutt AB; Handman E; Kelso A J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029 [TBL] [Abstract][Full Text] [Related]
20. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Heinzel FP; Sadick MD; Mutha SS; Locksley RM Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7011-5. PubMed ID: 1908085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]